WORCESTER, Mass., Jan. 22, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) announced today the publication of two scientific abstracts arising from collaborations between the Company’s Antigen Express immunotherapy subsidiary and Johns Hopkins University (www.jdu.edu) and Stallergenes S.A. (www.stallergenes.com). The focus of Antigen Express is on proprietary immunotherapeutic technologies that modulate the body’s response to foreign and endogenous agents by modulating their interaction with CD4+ T helper cells.
